Clinical Trials Insight: 700008828

Trial Profile

Clinical Trials Insight: 700008828

Phase of Trial: Phase I

Latest Information Update: 08 May 2008

At a glance

  • Drugs Ondansetron; Ondansetron
  • Indications Nausea; Nausea and vomiting; Vomiting
  • Focus Pharmacokinetics
  • Most Recent Events

    • 08 May 2008 NDA expected to be filed year end 2008.
    • 24 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top